Skip to main content
Article
Bifunctional inhibition of human immunodeficiency virus type 1 reverse transcriptase: mechanism and proof-of-concept as a novel therapeutic design strategy.
Journal of Medicinal Chemistry (2013)
  • Christopher M. Bailey, Yale University
  • Todd J. Sullivan, Yale University
  • Pinar Iyidogan, Yale University
  • Julian Tirado-Rives, Yale University
  • Raymond Chung, Harvard University
  • Juliana Ruiz-Caro, Yale University
  • Ebrahim Mohamed, University of Cape Town
  • William L. Jorgensen, Yale University
  • Roger Hunter, University of Cape Town
  • Karen S. Anderson, Arizona State University
Publication Date
May 23, 2013
DOI
10.1021/jm400160s
Citation Information
Christopher M. Bailey, Todd J. Sullivan, Pinar Iyidogan, Julian Tirado-Rives, et al.. "Bifunctional inhibition of human immunodeficiency virus type 1 reverse transcriptase: mechanism and proof-of-concept as a novel therapeutic design strategy." Journal of Medicinal Chemistry Vol. 56 Iss. 10 (2013) p. 3959 - 3968
Available at: http://works.bepress.com/todd-sullivan/3/